Irritable Bowel Syndrome and GERD/Ulcer Disease CME
May 19 - 22, 2002, San Francisco, California
Medscape's DDW Conference Coverage is an approved DDW program.
Release Date: June 7, 2002; Valid for credit through June 6, 2003
This activity has expired. CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.
Please note: The following announcement supercedes any information contained in this activity. On September 23, 2005, Boston Scientific issued a recall of all Enteryx Procedure Kits and Enteryx Injector Single Packs from commercial distribution. Serious adverse events, including death, occurred in patients treated with Enteryx, a liquid chemical polymer which is intended to be injected into the lower esophageal sphincter for treatment of gastroesophageal reflux disease. The serious adverse events involve unrecognized transmural injections of Enteryx into structures surrounding the esophagus.
Legal Disclaimer
The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing medical education activity.
